Kühne Holding AG has confirmed its agreement to acquire the contract development and manufacturing organization (CDMO), Aenova Group, from BC Partners, a private equity firm. This acquisition marks a significant expansion of Kühne Holding AG’s portfolio into the healthcare and pharmaceutical sectors, complementing its established interests in international logistics and shipping. Kühne Holding AG, headquartered […]
Monthly Archives: April 2024
The pharmaceutical industry is undergoing a transformation, driven by the innovative applications of Artificial Intelligence (AI) in drug development. As companies face growing pressures to reduce costs, expedite research, and enhance the efficacy of new therapies, AI is emerging as an indispensable asset. This article explores how AI is reshaping drug development, from discovery through […]
In the rapidly evolving landscape of the Contract Development and Manufacturing Organization (CDMO) industry, the integration of Artificial Intelligence (AI) is proving to be a game-changer. As CDMOs strive to meet the complex demands of drug development and manufacturing, AI emerges as a critical tool for enhancing efficiency, improving quality, and reducing time-to-market. Streamlining Development […]